These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 12662906

  • 1. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
    Hakura A, Suzuki S, Sawada S, Sugihara T, Hori Y, Uchida K, Kerns WD, Sagami F, Motooka S, Satoh T.
    Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
    [Abstract] [Full Text] [Related]

  • 2. Advantage of the use of human liver S9 in the Ames test.
    Hakura A, Suzuki S, Satoh T.
    Mutat Res; 1999 Jan 02; 438(1):29-36. PubMed ID: 9858674
    [Abstract] [Full Text] [Related]

  • 3. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A, Shimada H, Nakajima M, Sui H, Kitamoto S, Suzuki S, Satoh T.
    Mutagenesis; 2005 May 02; 20(3):217-28. PubMed ID: 15843387
    [Abstract] [Full Text] [Related]

  • 4. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
    Mori Y, Iimura K, Furukawa F, Nishikawa A, Takahashi M, Konishi Y.
    Mutat Res; 1995 Jan 02; 346(1):1-8. PubMed ID: 7530323
    [Abstract] [Full Text] [Related]

  • 5. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C, Kuroki T, Brun G, Hautefeuille A, Camus AM, Bartsch H.
    Mutat Res; 1979 Dec 02; 63(2):245-58. PubMed ID: 392308
    [Abstract] [Full Text] [Related]

  • 6. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K, Nohmi T, Miyata R, Ishidate M, Ozawa N, Isobe M, Watabe T, Kada T, Kawachi T.
    Mutat Res; 1982 Oct 02; 96(2-3):167-86. PubMed ID: 6755239
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of phenobarbital/beta-naphthoflavone as an alternative S9-induction regime to Aroclor 1254 in the rat for use in in vitro genotoxicity assays.
    Callander RD, Mackay JM, Clay P, Elcombe CR, Elliott BM.
    Mutagenesis; 1995 Nov 02; 10(6):517-22. PubMed ID: 8596471
    [Abstract] [Full Text] [Related]

  • 8. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y, Yamazaki H, Toyoshi K, Makino T, Obara T, Yokose Y, Konishi Y.
    Carcinogenesis; 1985 Mar 02; 6(3):415-20. PubMed ID: 3884171
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing.
    Burke DA, Wedd DJ, Herriott D, Bayliss MK, Spalding DJ, Wilcox P.
    Mutagenesis; 1994 Jan 02; 9(1):23-9. PubMed ID: 8208127
    [Abstract] [Full Text] [Related]

  • 10. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ, Ellingham TJ, Maddock MB.
    Mutat Res; 1986 Feb 02; 164(1):59-70. PubMed ID: 3512989
    [Abstract] [Full Text] [Related]

  • 11. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
    Prival MJ, Mitchell VD.
    Cancer Res; 1981 Nov 02; 41(11 Pt 1):4361-7. PubMed ID: 7030474
    [Abstract] [Full Text] [Related]

  • 12. Suppressed mutagenicity of benzo[a]pyrene by the liver S9 fraction and microsomes from eugenol-treated rats.
    Yokota H, Hoshino J, Yuasa A.
    Mutat Res; 1986 Dec 02; 172(3):231-6. PubMed ID: 3537779
    [Abstract] [Full Text] [Related]

  • 13. Mutagenic activation of carcinogenic N-nitrosopropylamines by liver S9 fractions from mice, rats and hamsters: evidence for a cytochrome P-450-dependent reaction.
    Mori Y, Yamazaki H, Toyoshi K, Denda A, Konishi Y.
    Carcinogenesis; 1986 Mar 02; 7(3):375-9. PubMed ID: 3512116
    [Abstract] [Full Text] [Related]

  • 14. Possible mechanisms of antimutagens by various teas as judged by their effects on mutagenesis by 2-amino-3-methylimidazo[4,5-f]quinoline and benzo[a]pyrene.
    Chen HY, Yen GC.
    Mutat Res; 1997 Sep 18; 393(1-2):115-22. PubMed ID: 9357568
    [Abstract] [Full Text] [Related]

  • 15. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
    Yamada K, Hakura A, Kato TA, Mizutani T, Saeki K.
    Mutat Res; 2005 Sep 05; 586(1):87-95. PubMed ID: 16087391
    [Abstract] [Full Text] [Related]

  • 16. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
    Kranendonk M, Mesquita P, Laires A, Vermeulen NP, Rueff J.
    Mutagenesis; 1998 May 05; 13(3):263-9. PubMed ID: 9643585
    [Abstract] [Full Text] [Related]

  • 17. Is a liver comparable to a liver? A comparison of different rat-derived S9-fractions with a biotechnological animal-free alternative in the Ames fluctuation assay.
    Brendt J, Crawford SE, Velki M, Xiao H, Thalmann B, Hollert H, Schiwy A.
    Sci Total Environ; 2021 Mar 10; 759():143522. PubMed ID: 33246726
    [Abstract] [Full Text] [Related]

  • 18. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
    Iba MM.
    Mutat Res; 1987 Oct 10; 182(5):231-41. PubMed ID: 3309638
    [Abstract] [Full Text] [Related]

  • 19. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
    Neis JM, Yap SH, van Gemert PJ, Roelofs HM, Bos RP, Henderson PT.
    Mutat Res; 1986 Feb 10; 164(1):41-51. PubMed ID: 3512987
    [Abstract] [Full Text] [Related]

  • 20. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
    Rashid KA, Babish JG, Johnson BE, Mumma RO.
    Toxicology; 1985 Aug 10; 36(2-3):139-46. PubMed ID: 3931301
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.